Burcu Isler

8PUBLICATIONS
16CO-AUTHORS
Innate immunityMedical infection agents (incl. prions)OrthopaedicsHealth equityMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 09, 2025
Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa.

Juan P Horcajada, Ana C Gales, Burcu Isler

|Aug 14, 2025
Advancing the management of prosthetic joint infections: a review of randomized controlled trials and emerging evidence.

Burcu Isler, Zhenya Welyczko, Nicholas Jorgensen

|Mar 30, 2024
Addressing important evidence gaps in the management of prosthetic joint infection: clinician attitudes and equipoise.

Burcu Isler, Natalie Niessen, David Campbell

|Jul 05, 2021
PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales.

David L Paterson, Burcu Isler, Patrick N A Harris

Pageof 2